ECSP20024549A - INHIBITORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR - Google Patents
INHIBITORS OF THE EPIDERMAL GROWTH FACTOR RECEPTORInfo
- Publication number
- ECSP20024549A ECSP20024549A ECSENADI202024549A ECDI202024549A ECSP20024549A EC SP20024549 A ECSP20024549 A EC SP20024549A EC SENADI202024549 A ECSENADI202024549 A EC SENADI202024549A EC DI202024549 A ECDI202024549 A EC DI202024549A EC SP20024549 A ECSP20024549 A EC SP20024549A
- Authority
- EC
- Ecuador
- Prior art keywords
- growth factor
- factor receptor
- epidermal growth
- inhibitors
- present
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona a un compuesto nuevo de fórmula I, o a sales de uso farmacéutico aceptable, solvatos o estereoisómeros de los mismos, también a una composición farmacéutica, un método para la inhibición de la actividad biológica del receptor del factor de crecimiento epidérmico (EGFR), un método para tratar una enfermedad o una trastorno mediada por la activación del EGFR y el uso de los presentes compuestos o de la presente composición farmacéutica para el tratamiento de una enfermedad o trastorno mediada por la activación del EGFR.The present invention relates to a new compound of formula I, or to salts of acceptable pharmaceutical use, solvates or stereoisomers thereof, also to a pharmaceutical composition, a method for the inhibition of the biological activity of the epidermal growth factor receptor ( EGFR), a method of treating a disease or disorder mediated by EGFR activation and the use of the present compounds or the present pharmaceutical composition for the treatment of a disease or disorder mediated by EGFR activation.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2017135686A RU2017135686A (en) | 2017-10-06 | 2017-10-06 | Epidermal Growth Factor Receptor Inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP20024549A true ECSP20024549A (en) | 2020-06-30 |
Family
ID=66089516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202024549A ECSP20024549A (en) | 2017-10-06 | 2020-05-06 | INHIBITORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR113691A1 (en) |
| EC (1) | ECSP20024549A (en) |
| MA (1) | MA49606B1 (en) |
| RU (1) | RU2017135686A (en) |
-
2017
- 2017-10-06 RU RU2017135686A patent/RU2017135686A/en not_active Application Discontinuation
-
2018
- 2018-10-05 MA MA49606A patent/MA49606B1/en unknown
- 2018-10-08 AR ARP180102908A patent/AR113691A1/en unknown
-
2020
- 2020-05-06 EC ECSENADI202024549A patent/ECSP20024549A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017135686A (en) | 2019-04-08 |
| MA49606B1 (en) | 2021-12-31 |
| MA49606A1 (en) | 2020-11-30 |
| AR113691A1 (en) | 2020-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020004201A2 (en) | Epidermal growth factor receptor inhibitor | |
| CL2019002204A1 (en) | HIV inhibitor compounds. | |
| CU20160109A7 (en) | INDAZOL COMPOUNDS AS IRAK4 INHIBITORS | |
| EA201890308A1 (en) | SUBSTITUTED ASO COMPOUNDS AS IRAK-4 INHIBITORS | |
| DOP2015000158A (en) | PRMT5 INHIBITORS AND THEIR USES | |
| EA201890307A1 (en) | INDASOLIC AND AZAINDASOLIC COMPOUNDS AS IRAK-4 INHIBITORS | |
| EA201692268A1 (en) | PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | |
| EA201692249A1 (en) | PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | |
| CU20160188A7 (en) | INDAZOLE COMPOUNDS SUBSTITUTED AS IRAK4 INHIBITORS | |
| CO2018001268A2 (en) | Heteroaryl derivatives as parp inhibitors | |
| EA201691803A1 (en) | HUMAN PLASMA KALLIKREIN INHIBITORS | |
| CU20160111A7 (en) | BICYCLIC HETEROCICLYL COMPOUNDS AS IRAK4 INHIBITORS | |
| EA201790921A1 (en) | SUBSTITUTED DERIVATIVES OF 2-ANILINPYRIMIDIN AS EGFR MODULATORS | |
| CL2016003422A1 (en) | Lysine specific demethylase-1 inhibitors | |
| CO2017003838A2 (en) | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | |
| EA201692266A1 (en) | PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | |
| DOP2013000263A (en) | COMPOUNDS OF 2- (2,4,5-REPLACED ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USED FOR CANCER TREATMENT | |
| EA201692267A1 (en) | PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | |
| CL2016003423A1 (en) | Lysine specific demethylase-1 inhibitors | |
| EA201692265A1 (en) | PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | |
| MD3221298T2 (en) | 4-Oxo-3,4-dihydro-1,2,3-benzotriazine derivatives as modulators of GPR139 | |
| EA202193015A1 (en) | CDK INHIBITORS | |
| DOP2016000308A (en) | COMPOUNDS OF 1, 3, 4-TIADIAZOL AND USE OF THE SAME FOR THE TREATMENT OF CANCER | |
| CL2020001140A1 (en) | Spirocyclic compounds as modulators of the x-farnesoid receptor. | |
| CO2017000011A2 (en) | Quinolizinone derivatives as pi3k inhibitors |